Anixa Biosciences (ANIX) Other Working Capital Changes (2023 - 2025)
Anixa Biosciences' (ANIX) quarterly Other Working Capital Changes came in at -$9000.0 in Q4 2025, down 80.0% YoY from -$45000.0 in Q4 2024, and down 12.5% on a QoQ basis from -$8000.0 in Q3 2025.
Anixa Biosciences (ANIX) Other Working Capital Changes (2023 - 2025) Analysis & Trends
Anixa Biosciences (ANIX) has 3 years of Other Working Capital Changes data on file, last reported at -$9000.0 in Q4 2025.
- Quarterly Other Working Capital Changes fell 80.0% year-over-year to -$9000.0 in Q4 2025, while the trailing twelve-month figure through Oct 2025 was -$28000.0 (up 34.88% YoY) and the FY2025 annual result came in at -$28000.0, up 34.88% from the prior year.
- Other Working Capital Changes retreated to -$9000.0 in Q4 2025, from -$8000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $758000.0 in Q3 2024 to a low of -$707000.0 in Q4 2025.
- A 5-year average of $19950.0 and a median of -$104000.0 in 2022 frame the typical range for Other Working Capital Changes.
- The widest YoY moves for Other Working Capital Changes: up 84.62% in 2025, down 80.0% in 2025.
- Tracing ANIX's Other Working Capital Changes over 3 years: stood at -$12000.0 in 2023, then soared by 58.33% to -$5000.0 in 2024, then tumbled by 80.0% to -$9000.0 in 2025.
- The last three Other Working Capital Changes figures came in at -$9000.0 (Q4 2025), -$8000.0 (Q3 2025), and -$9000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Anixa Biosciences | 121.44 Mn | 121.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | -9,000.00 |
| Oct 31, 2025 | -9,000.00 |
| Oct 31, 2025 | -9,000.00 |
| Jul 31, 2025 | -8,000.00 |
| Jul 31, 2025 | -8,000.00 |
| Jul 31, 2025 | -8,000.00 |
| Apr 30, 2025 | -9,000.00 |
| Apr 30, 2025 | -9,000.00 |
| Apr 30, 2025 | -9,000.00 |
| Jan 31, 2025 | -2,000.00 |
| Jan 31, 2025 | -2,000.00 |
| Jan 31, 2025 | -2,000.00 |
| Oct 31, 2024 | -5,000.00 |
| Oct 31, 2024 | -5,000.00 |
| Oct 31, 2024 | -5,000.00 |
| Jul 31, 2024 | -12,000.00 |
| Jul 31, 2024 | -12,000.00 |
| Jul 31, 2024 | -12,000.00 |
| Apr 30, 2024 | -13,000.00 |
| Apr 30, 2024 | -13,000.00 |